COMMODORE CAPITAL LP
Related Filers (25)
- Satsuma Pharmaceuticals, Inc. (17)
- Enliven Therapeutics, Inc. (9)
- Vistagen Therapeutics, Inc. (7)
- Vera Therapeutics, Inc. (6)
- Celcuity Inc. (4)
- Cogent Biosciences, Inc. (4)
- CymaBay Therapeutics, Inc. (4)
- Ambrx Biopharma Inc. (4)
- Merus N.V. (3)
- IMMUNIC, INC. (3)
- BELLUS Health Inc. (3)
- GENOCEA BIOSCIENCES, INC. (2)
- Viridian Therapeutics, Inc.\DE (2)
- Cabaletta Bio, Inc. (2)
- Karyopharm Therapeutics Inc. (2)
- Adverum Biotechnologies, Inc. (2)
- SOLENO THERAPEUTICS INC (2)
- SAB Biotherapeutics, Inc. (2)
- Spyre Therapeutics, Inc. (2)
- Viridian Therapeutics, Inc. (1)
- Nkarta, Inc. (1)
- Harpoon Therapeutics, Inc. (1)
- C4 Therapeutics, Inc. (1)
- Adicet Bio, Inc. (1)
- Ambrx Biopharma, Inc. (1)
- Show More ...
Other (16)
13F-HR/A
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/15/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Thursday, 10/14/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Thursday, 10/14/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/17/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (86)
SC 13G/A
Wednesday, 2/14/2024
IMMUNIC, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Enliven Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Celcuity Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Vera Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Ambrx Biopharma, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Spyre Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Merus N.V.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Cogent Biosciences, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Adverum Biotechnologies, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
SOLENO THERAPEUTICS INC: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
SAB Biotherapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Vera Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Cabaletta Bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
CymaBay Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 1/19/2024
Adicet Bio, Inc.: Major Shareholders
4
Friday, 1/12/2024
Vera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 12/22/2023
C4 Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 12/1/2023
Spyre Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 11/3/2023
Harpoon Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 10/27/2023
Nkarta, Inc.: Major Shareholders
SC 13G
Monday, 10/16/2023
SAB Biotherapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 10/12/2023
SOLENO THERAPEUTICS INC: Major Shareholders
SC 13G/A
Friday, 10/6/2023
Vistagen Therapeutics, Inc.: Major Shareholders
4
Friday, 10/6/2023
Vistagen Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Wednesday, 8/9/2023
Vistagen Therapeutics, Inc.: Major Shareholders
4
Wednesday, 8/9/2023
Vistagen Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/9/2023
Vistagen Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/22/2023
Vera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/22/2023
Vera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Thursday, 4/27/2023
Ambrx Biopharma Inc.: Major Shareholders
SC 13G
Monday, 4/24/2023
Enliven Therapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 4/20/2023
Adverum Biotechnologies, Inc.: Major Shareholders
SC 13G
Thursday, 3/30/2023
BELLUS Health Inc.: Major Shareholders
3
Friday, 3/3/2023
Ambrx Biopharma Inc.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 3/3/2023
Ambrx Biopharma Inc.: Major Shareholders
SC 13G/A
Friday, 3/3/2023
Ambrx Biopharma Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/28/2023
Enliven Therapeutics, Inc.: Major Shareholders
4
Monday, 2/27/2023
Enliven Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/23/2023
IMARA Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/21/2023
IMARA Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/21/2023
IMARA Inc.: Major Shareholders
SC 13G
Thursday, 2/16/2023
Vera Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
CymaBay Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
IMARA Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
IMMUNIC, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Merus N.V.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Cogent Biosciences, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
VistaGen Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Karyopharm Therapeutics Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Viridian Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Celcuity Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
BELLUS Health Inc.: Major Shareholders
SC 13G
Friday, 1/13/2023
Cabaletta Bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 11/16/2022
Satsuma Pharmaceuticals, Inc.: Major Shareholders
4
Wednesday, 11/16/2022
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 10/24/2022
IMARA Inc.: Major Shareholders
SC 13G
Friday, 10/21/2022
IMMUNIC, INC.: Major Shareholders
SC 13G
Thursday, 5/19/2022
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G
Monday, 5/16/2022
Merus N.V.: Major Shareholders
SC 13G
Monday, 5/9/2022
Karyopharm Therapeutics Inc.: Major Shareholders
SC 13G
Thursday, 4/14/2022
VistaGen Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Satsuma Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
CymaBay Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 2/14/2022
BELLUS Health Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Cogent Biosciences, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Celcuity Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
GENOCEA BIOSCIENCES, INC.: Major Shareholders
4
Monday, 11/29/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/23/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/12/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/10/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 11/4/2021
Cogent Biosciences, Inc.: Major Shareholders
4
Thursday, 11/4/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/2/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/29/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/25/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/21/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 10/19/2021
Satsuma Pharmaceuticals, Inc.: Major Shareholders
4
Tuesday, 10/19/2021
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/19/2021
Satsuma Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Monday, 7/12/2021
CymaBay Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 7/9/2021
Celcuity Inc.: Major Shareholders
SC 13G
Wednesday, 3/31/2021
GENOCEA BIOSCIENCES, INC.: Major Shareholders
SC 13G
Monday, 3/15/2021
Satsuma Pharmaceuticals, Inc.: Major Shareholders